A prospective U. S. cohort set within health care systems to study cancer
Added: Jun 21, 2016 2:21 pm
Type of Notice:This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement.Background:The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG) focuses on research to discover genetic and environmental determinants of cancer and identifying new approaches to cancer prevention.Purpose and Objectives:DCEG plans to build a prospective multi-center adult cohort study of 150,000-200,000 adult participants enrolled through U.S. integrated health care systems to study the causes of cancer and the means of its prevention. The core objectives of the cohort are for participants to complete an online consent followed by an online questionnaire, and provide blood and urine donation as well as possibly discard samples (e.g. discard Fecal Immunochemical Test (FIT) cards). The cohort will additionally have all of the desirable attributes of a contemporary study as part of its core research objectives including serial biospecimens, tumor tissue, comprehensive data from Electronic Medical Records (EMR) on elements such as drug prescription, medical conditions and procedures, and repeated questionnaires combined with reliable passive and long-term follow-up strategies for cancer ascertainment. In addition to providing a rich source of information for a wide variety of hypotheses about the etiology of cancer, the cohort infrastructure will also be designed to allow investigation of non-cancer outcomes (e.g. cardiovascular events, diabetes). It would also allow for enhancements to be added at any phase to allow more detailed assessment of certain exposures (e.g. environmental exposures, lifestyle factors), collection of additional specimens (e.g. oral wash, stool), and to facilitate patient-centered and health delivery research to improve patient care through evidence-based decisions.Project Requirements:Three separate acquisitions are anticipated to create the proposed successful large-scale cohort, including a support service contractor for field activities (see Sources Sought Notice HHS-NIH-NCI-SS-ETSB-1007-58); software solutions for IT systems infrastructure (See Sources Sought Notice HHS-NIH-NCI-ETSB-1008-58); and integrated health care system(s) to serve as recruitment sites. As part of market research, a Pre-Solicitation Conference for this project was held on June 2, 2016 (See Special Notice HHS-NIH-NCI-SN-Pre-SolicitationConference-ETSB-0000-58).This notice pertains to the integrated health care systems to serve as recruitment sites. Potential awards to recruitment sites will be to integrated health care systems to recruit and retain participants, collect and process biospecimens, link to electronic medical records, and serve on the governance committee. The recruitment sites will identify eligible health plan members. All eligible health plan members will be invited to participate in the cohort electronically. The following are the key tasks for the recruitment sites to meet the core objectives:The project will require integrated health care systems to recruit, enroll, follow-up and retain study participants identified in their own integrated health care system. Specific tasks to be performed by the Contractor include the following:Work cooperatively with the NCI, third party contractors (e.g. contractors for support service and software solution for IT systems infrastructure) and other field centers in all relevant aspects of study development and execution to produce the best science and maximize cost-effectiveness and efficiency of the study. 1. Collaborate with NCI and NCI support service contractor to develop and/or modify study protocols and materials customized to meet site-specific requirements.2. Work cooperatively with all study investigators and staff, the NCI, and any consultants in all relevant aspects of the study. Perform administrative, operational, and technical duties to support productive collaboration among the study personnel at all sites, NCI, and the NCI support service contractor.3. Participate collaboratively in study committees to provide a transparent committee process, open access to study documents, clear policies for access to data and materials, and an approval process for proposed studies, manuscripts, and ancillary studies that is fair and balanced. 4. Host one site visit per year at each field site.Prepare for participant recruitment and follow-up.1. Obtain IRB approval.2. Generate or modify algorithms as appropriate to identify eligible participants and pull selected demographic data used to determine eligibility (e.g. age, race, gender) from the electronic medical records as specified by NCI. 3. In collaboration with the NCI support service contractor, coordinate training and certification for study staff as required.4. Implement appropriate quality assurance and quality control programs.5. Work collaboratively with NCI, the NCI support service and software solutions contractor to facilitate integration of databases/systems with the IT systems infrastructure for coordination and management of field activities.Implement study protocol. Perform a run-in phase to recruitment and specimen collection to identify and resolve any barriers to successful implementation of the full study. Upon successful implementation of the protocol during the run-in phase, conduct full-scale recruitment and follow-up of participants. Develop and/or modify and validate algorithms to abstract exposure and disease outcomes data from electronic medical records. Collect specimens (e.g. blood, urine, and other specimens) within existing clinical infrastructure.1. Collect biological specimens from participants according to standardized operating protocols (SOPs). 2. Process biological specimens according to standardized operating protocols (SOPs). 3. Develop and/or modify and validate algorithms to abstract selected data from EMR. Deliver abstracted data in a format specified by NCI to the cohort data repository. Perform regular routine updates of data to data stored in a central data repository as well as creating/modifying algorithms for new data abstraction to be included in the central data repository.Engage participants. Serve as the point of contact for interested individuals and enrolled participants.1. While consent will be obtained electronically and questionnaires will be administered online by third party servicer, the recruitment site will serve as the point of contact for individuals and participants who would like additional information or have questions.2. Host a toll-free study telephone line to answer questions from individuals and participants for all stages of the study (e.g. general study information, pre-enrolling questions, questionnaire issues, blood donation issues and engage with study participants throughout the follow-up phases.Anticipated Period of Performance:The anticipated period of performance for this requirement is a five-year base period, with five one-year option periods.Capability Statement/Information Sought:We encourage all responsible sources, particularly small businesses, to submit a capability statement which will be considered by the agency. Organizations that submit capability statements in response to this notice shall clearly document and demonstrate the capability to accomplish the following:1. That the health care system has coordinated and integrated care provision, which ensures that all health care services received by members are captured through electronic medical records. If any services are not covered/captured through electronic medical records, details of these should be documented.2. Provide an estimate on the number of potentially eligible study participants (members who have been cancer free for at least 1 year) by age (30-39,40-49,50-59,60-69,70+), race (American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, Native Hawaiian or Other Pacific Islander, White), and gender (Male, Female).3. Ability to recruit study participants among eligible health plan members by email. If not, document ability to recruit study participants through alternative invitation method(s). 4. Ability to, or future ability to, build a system within existing infrastructure to perform automated data abstraction from Electronic Medical Records (EMR).5. Ability and willingness to build a system within existing infrastructure to share abstracted EMR data with researchers outside of respondent's institutions.6. Ability to or future ability to build a system within existing infrastructure to place individual orders for specimen collections (e.g. blood, urine). 7. Ability or future ability to process samples following study-specific protocols. 8. Ability or future ability to build a system within existing infrastructure to collect tissue from consented participants. 9. Ability and willingness to work with collaborators on multi-center research projects.Interested qualified organizations should submit a tailored capability statement for this requirement, not to exceed 20 single-sided pages (including all attachments, resumes, charts, etc.) presented in single-space using a 12-point font size minimum, that clearly details the ability to perform the aspects of the notice described above. Capability statements should also include an outline of previous or similar projects performed. All statements must include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement, as well as the eligible small business concern's name, point of contact, address and DUNS number.Information Submission Instructions:All capability statements sent in response to this SOURCES SOUGHT notice must be submitted electronically (via email) to Rosa Lopez, Contract Specialist, at rosa.lopez@nih.gov and Jill Johnson, Contracting Officer at jill.johnson2@nih.gov in MS Word or Adobe Portable Document Format (PDF), by July 11, 2016 3:00PM, EST. All responses must be received by the specified due date and time in order to be considered. No collect calls or facsimile transmissions will be accepted.Disclaimer and Important Notes:This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised the Government is under no obligation to acknowledge receipt of the information received or provide feedbacks to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
HHS-NIH-NCI-SS-ETSB-1009-58 Department of Health and Human Services National Institutes of Health
6/21/16, 2:21 PM Clinically Managed & Medically Monitored Detoxification
Added: Jun 09, 2014 12:44 pm
The Court Services and Offender Supervision Agency (CSOSA) is issuing this RFP for the acquisition of the following Social Rehabilitation Service for its offender population (men, women, and sex offenders) within the District of Columbia. Services to be solicited are:Medically Monitored Detoxification Services (3-10 Day Treatment plan)This solicitation requires vendors to provide facilities, labor, material and equipment necessary to perform the above service. This solicitation is issued with the intention of awarding one (and at most two) Firm Fixed Price (FFP) Daily rate contract(s) for these Detoxification Services. The resulting contract will have a total length or performance period of five (5) years, consisting of one (1) 12 month base award period with four (4) one-year options. The Government will make the award to the lowest price, technically acceptable (LPTA) offeror IAW FAR 15.101-2. The evaluation criteria will consist of three (3) evaluation factors: Technical Acceptability, Past Performance, and Price. The factors, terms and conditions are set forth in the attached solicitation.This acquisition is subject to the requirement of FAR 4.1102 (a)-System for Award Management. Interested vendors must be registered in the System for Award Management (SAM) (www.sam.gov) to be considered as a potential source.This notice does constitute a Request for Proposal (RFP). Questions may be submitted by 4 pm EDT, 30 June, 2014. The federal government will post the responses to the questions to www.fbo.gov.The Solicitation Period Closing Date is: 7 July 2014, 4:00 PM.Thank you for your interest in our solicitation.
CSOSA-14-R-0029 Court Services and Offender Supervision Agency
6/9/14, 12:44 PM DHA Industry Partner Network (IPN) Request For Information (RFI) :Value-Based Care Purchasing Initiatives
DHA Industry Partnership Network (IPN) Request for Information (RFI) - Special Notice TITLE: Value-Based Care Purchasing Initiatives INTRODUCTION: The Department of Defense, Defense Health Agency (DHA) seeks information from knowledgeable sources to conduct pilot projects and/demonstration projects that will inform the next generation TRICARE programs. DHA is seeking information about industry best practices and initiatives to understand how industry implements Value Based Purchasing (VBP) programs that align provider incentives with desired behaviors and quality outcomes. Industry's perspective will help chart the course to implement alternative payment methodologies and incentives to base reimbursements to private sector care providers on quality of care or other measures - not on the volume and quantity of services they provide. The Department's goal is to understand Industry's perspectives, business model and risks associated with Value-Based Purchasing. BACKGROUND: The TRICARE benefit is not insurance, but rather a benefit program established in law and federal regulation. Although the TRICARE program is available worldwide, DHA would focus VBP initiatives in the United States. TRICARE offers TRICARE Prime programs, which are similar to the health maintenance organization model; assignment to a Primary Care Manager (PCM) at a Military Treatment Facility (MTF) is given priority over assignment to a PCM in the TRICARE network. TRICARE also offers TRICARE Select, which includes network and non-network care with no referrals required. TRICARE already has a cost advantage since TRICARE provider reimbursement rates are tied to Medicare rates by law to the maximum extent practicable. DHA uses two regional contractors to administer the TRICARE program in the U.S, one in the East region and one in the West region (see https://tricare.mil/About/Regions). The regional contractors support the DHA and MTF efforts to provide TRICARE eligible beneficiaries access to high quality health care. The regional contractors provide program management, coverage determinations, medical care management, customer services, provider networks, and claims processing. The TRICARE network must be adequate to meet TRICARE Prime access standards. Although, the provider networks were generally limited to the 40-mile area around Military Treatment Facilities (MTFs) before this year, the contractors are expanding the network to ensure that the network covers at least 85 percent of the TRICARE Select enrolled population. he TRICARE Program is available in the United States and requires enrollment by eligible beneficiaries. The TRICARE contractors create and manage the provider networks, process claims and provide administrative functions in support of the program. AUTHORITY: The DHA Component Acquisition Executive J-4 is issuing this Special Notice Request for Information (RFI) for the purpose of Market Research as required by the Federal Acquisition Regulation (FAR) 15.201 and FAR 10.002. This notice does not obligate the Government to award a potential contract or otherwise pay for the information provided in response. Responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract. GENERAL INDUSTRY PARTNERSHIP NETWORK (IPN) PURPOSE: The DHA IPN Program, within the Component Acquisition Executive (CAE) (J-4) Directorate at the DHA, intends to use industry responses and communications from this notice as market research for subsequent acquisition strategies. DHA seeks information on availabilities, capabilities, and other pertinent marketplace data to strengthen the DHA's understanding of the current and future marketplace to enhance its ability to obtain quality services economically and to efficiently and lawfully establish potential vendor source files, listings and requirements. The DHA will not award any contracts under this notice. INFORMATION SOUGHT BY THE DHA: We invite industry, to include commercial health plans, the Veterans Health Administration, the Centers for Medicare and Medicaid (CMS), health care industry / trade organizations, and academia to share perspectives about value based care initiatives and programs. This includes, but is not limited to the CMS Value Based Purchasing Program. The submissions provided should address each of the following questions: Performance Assessment and Overall Effectiveness of Value-Based Purchasing Question 1: What reasoning drove you to implement VBP? What approaches do you use for VBP? What have you found most effective? Least effective? Question 2: What reimbursement methodologies has your organization found useful to improve value and quality of care and why? (e.g., bundled payments, episode of care payments, accountable care organizations, shared savings for acceptance of risk, global payments or capitation, care management fee, or quality incentives.) Value-Based Incentives and Best Practices Question 3: What have you found to be the most effective tools for driving quality outcomes and controlling costs? Question 4: What are your key lessons learned from implementing VBP or other incentives aligned with performance? What are the keys to successful risk sharing? What approaches to sharing risk with the providers have you found to be the most effective? Key Performance Indicators and Data Reporting Question 5: What process, outcome, or experience of care and efficiency KPIs do you measure/evaluate for Value-Based purchasing in your commercial plans? Question 6: What are the keys to data points, data collection and analysis to successfully implement VBP? How do you assure accurate reporting of measures and outcomes? How do you set the target benchmarks for your KPIs? What data sources do you pull from? (e.g., NSQIP, NCQA, etc.) What reporting tools or systems are you currently using? Value, Quality, and TRICARE Question 7: What other opportunities exist in Value-Based Purchasing to improve TRICARE? Question 8: What are industry best practices for measuring clinical quality outcomes? Challenges Question 9: What are some of the challenges you have faced from implementing and sustaining VBP? DISCLAIMER AND IMPORTANT NOTES: THIS NOTICE IS NOT A REQUEST FOR PROPOSALS. This notice constitutes solely a market research effort as described under FAR 10.002. This notice does not obligate the Government to award a potential contract or otherwise pay for the information provided in response. The Government may invite certain respondents to an in-person meeting as a follow-up to this RFI. The Government will not pay for expenses related to this in-person meeting. The Government reserves the right to use results of the communications with industry for any purpose consistent with, and not otherwise prohibited by FAR Part 10. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, in no case shall responses to this notice be considered either a response to a solicitation or a submission of an unsolicited proposal, as defined by FAR 2.101. CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. Industry responses will be shared with DHA staff for the purpose of market research. All materials will be presented in an environment that protects proprietary information. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). NEXT STEPS: Submittals should be emailed to the Government's IPN team on or before 4:00 pm Eastern Time on 22 October 2018. Responses to this RFI should be no more than 10 pages and should address each of the questions asked by the DHA in the Information Sought portion of this RFI. The Government may not review submissions that fail to address each of the questions in the section title, "Information Sought by the Government." If companies wish to include a general capability statement, it should be attached separately. All responses will be reviewed and assessed by DHA staff. Several potential industry sources may subsequently be invited to present at an in-person meeting with the Government on November 08-09, 2018. If selected, the POC sending the submission will be contacted via email to schedule a 45 min presentation to the DHA Value-Based Purchasing Council during the DHA Industry Forum (November 08-09, 2018) at La Cantera, San Antonio Texas. In your response, please indicate the priority for a one-on-one meeting time: •a) 8 Nov morning •b) 8 Nov afternoon •c) 9 Nov morning •d) 9 Nov afternoon Selected presenters will be required to submit final presentation materials by 4:00 pm Eastern Time on November 02, 2018. Each of the responses will be maintained by the DHA as a source of market research information and published on an internal SharePoint site. We greatly appreciate your time and look forward to learning from the submission. PRIMARY POINTS OF CONTACT: Submit RFI response and/or questions to DHA IPN Team email: dha.ncr.acquisition.mbx.dha-ipn@mail.mil .
HT0050IPNRFI7_2018Oct3 Defense Health Agency
10/3/18, 3:07 PM